CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory
Open Access
- 21 April 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (4) , e18726
Abstract
There are few large published studies of HIV controllers with long-term undetectable viral load (VL). We describe the characteristics and outcomes of 81 French HIV controllers. HIV controllers were defined as asymptomatic, antiretroviral-naïve persons infected ≥10 years previously, with HIV-RNA 90% of plasma samples. All available CD4 and VL values were collected at enrolment. Mixed-effect linear models were used to analyze CD4 cell count slopes since diagnosis. HIV controllers represented 0.31% of all patients managed in French hospitals. Patients infected through intravenous drug use were overrepresented (31%) and homosexual men were underrepresented (26% of men) relative to the ANRS SEROCO cohort of subjects diagnosed during the same period. HIV controllers whose VL values were always below the detection limit of the assays were compared with those who had rare “blips” (50% of VL values above the detection limit). Estimated CD4 cell counts at HIV diagnosis were similar in the three groups. CD4 cell counts remained stable after HIV diagnosis in the “no blip” group, while they fell significantly in the two other groups (−0.26√CD4 and −0.28√CD4/mm3/year in the rare and frequent blip groups, respectively). No clinical, immunological or virological progression was observed in the no blip group, while 3 immunological and/or virological events and 4 cancers were observed in the blip subgroups. Viral blips in HIV controllers are associated with a significant decline in CD4 T cells and may be associated with an increased risk of pathological events, possibly owing to chronic inflammation/immune activation.Keywords
This publication has 31 references indexed in Scilit:
- Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History StudyThe Journal of Infectious Diseases, 2009
- Persistent Low‐Level Viremia in HIV‐1 Elite Controllers and Relationship to Immunologic ParametersThe Journal of Infectious Diseases, 2009
- Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosisAIDS, 2009
- Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIVAIDS, 2009
- Epidemiologic Characteristics and Natural History of HIV-1 Natural Viral SuppressorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Viral Load and CD4+ T-Cell Dynamics in Primary HIV-1 Subtype C InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 StudyPLOS ONE, 2008
- Relationship between T Cell Activation and CD4+T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of TherapyThe Journal of Infectious Diseases, 2008
- Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite SuppressorsJournal of Virology, 2007
- Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutationsJournal of Experimental Medicine, 2006